Eisai Co. Ltd.'s Fiscal Year is From April To March.
The item "Financial-Leverage-Ratio" stands at 1.67 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eisai Co. Ltd.'s second quarter, the item "Financial Leverage Ratio" stands at 1.67. This represents an increase of 1.07 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.43 percent compared to the value the year prior.
The 1 year change in percent is 4.43.
The 3 year change in percent is 5.20.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Financial Leverage Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Financial Leverage Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Financial Leverage Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Financial Leverage Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Financial Leverage Ratio | 280,205,508,085.11 |